Hilton Capital Management’s Merck MRK Stock Holding History

Hilton Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.5M	Buy	37,392 +1,497	+4%	+$173K	0.34%	66
2025 Q4	$3.78M	Buy	+35,895	New	+$3.37M	0.28%	80
2025 Q2	–	Sell	-2,304	Closed	-$207K	–	179
2025 Q1	$207K	Sell	2,304 -40,792	-95%	-$3.81M	0.02%	160
2024 Q4	$4.29M	Sell	43,096 -5,697	-12%	-$587K	0.37%	64
2024 Q3	$5.54M	Buy	48,793 +860	+2%	+$102K	0.43%	57
2024 Q2	$5.93M	Buy	47,933 +1,504	+3%	+$194K	0.5%	53
2024 Q1	$6.13M	Sell	46,429 -203	-0.4%	-$25K	0.55%	50
2023 Q4	$5.08M	Sell	46,632 -16	-0%	-$1.66K	0.54%	53
2023 Q3	$4.8M	Sell	46,648 -2,422	-5%	-$261K	0.64%	42
2023 Q2	$5.66M	Sell	49,070 -1,028	-2%	-$117K	0.68%	39
2023 Q1	$5.56M	Buy	+50,098	New	+$5.41M	0.73%	35
2020 Q4	–	Sell	-2,572	Closed	-$204K	–	117
2020 Q3	$204K	Buy	+2,572	New	+$201K	0.02%	77
2020 Q2	–	Sell	-2,795	Closed	-$205K	–	92
2020 Q1	$205K	Buy	2,795 +52	+2%	+$4.09K	0.04%	52
2019 Q4	$238K	Buy	2,743 +139	+5%	+$11.4K	0.03%	93
2019 Q3	$209K	Buy	2,604 +492	+23%	+$39.4K	0.03%	98
2019 Q2	$169K	Hold	2,112	–	–	0.02%	116
2019 Q1	$168K	Sell	2,112 -2,149	-50%	-$161K	0.02%	124
2018 Q4	$311K	Buy	4,261 +112	+3%	+$7.91K	0.06%	94
2018 Q3	$281K	Buy	4,149 +330	+9%	+$21K	0.04%	104
2018 Q2	$221K	Buy	+3,819	New	+$215K	0.04%	116
2017 Q4	–	Sell	-4,564	Closed	-$279K	–	142
2017 Q3	$279K	Buy	4,564 +1,064	+30%	+$64.5K	0.05%	103
2017 Q2	$214K	Sell	3,500 -8,458	-71%	-$515K	0.04%	106
2017 Q1	$725K	Buy	+11,958	New	+$725K	0.14%	57
2016 Q4	–	Sell	-24,875	Closed	-$1.48M	–	129
2016 Q3	$1.48M	Buy	+24,875	New	+$1.45M	0.37%	42
2016 Q1	–	Sell	-4,828	Closed	-$243K	–	98
2015 Q4	$243K	Buy	4,828 +63	+1%	+$3.18K	0.08%	75
2015 Q3	$225K	Sell	4,765 -157	-3%	-$8.34K	0.08%	77
2015 Q2	$267K	Sell	4,922 -121	-2%	-$6.79K	0.08%	81
2015 Q1	$278K	Buy	5,043 +177	+4%	+$10K	0.1%	68
2014 Q4	$264K	Buy	4,866 +102	+2%	+$5.68K	0.09%	75
2014 Q3	$269K	Hold	4,764	–	–	0.08%	65
2014 Q2	$263K	Sell	4,764 -92	-2%	-$5.02K	0.09%	72
2014 Q1	$263K	Hold	4,856	–	–	0.1%	72
2013 Q4	$232K	Hold	4,856	–	–	0.09%	76
2013 Q3	$221K	Hold	4,856	–	–	0.11%	73
2013 Q2	$215K	Buy	+4,856	New	+$217K	0.1%	75

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hilton Capital Management's MRK Position: Q1 2026 in Review

Hilton Capital Management increased its Merck (MRK) stake by 4.2% in Q1 2026, buying an estimated $173K and bringing the position to 37,392 shares worth $4.5M. The position accounts for 0.34% of the portfolio, ranked #66.

Hilton Capital Management first reported a position in MRK in Q2 2013 and has held it in 35 quarters since. The position peaked at $6.13M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Hilton Capital Management held 37,392 shares of Merck worth $4.5M as of Q1 2026.
Hilton Capital Management bought 1,497 Merck shares in Q1 2026, an estimated $173K.
Merck made up 0.34% of Hilton Capital Management's portfolio in Q1 2026, its #66 holding.
Hilton Capital Management first reported a position in Merck in Q2 2013 and has held it in 35 quarters since.
Hilton Capital Management's Merck position peaked at $6.13M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hilton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.